Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical vs. Intravenous Tranexamic Acid in Open Cardiac Surgery
NCT03954314Phase 3Terminated
- Sponsor
- Population Health Research Institute
- Start
- Sep 2019
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 6
01
Overview
Phase 3, randomised, double-blind trial of tranexamic acid in seizure (2 arms), sponsored by Population Health Research Institute. Primary endpoint: Proportion of Patients Experiencing an In-hospital Seizure at 10 days. Started Sep 2019; status: terminated.
02
Drugs
tranexamic acid
03
Conditions
seizure
Beyond the preview
Go deeper on NCT03954314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03954314.